A group from Fujita Health University has identified the first known case of posterior reversible encephaliopathy syndrome (PRES) associated with HHV-6B encephalitis.
New study shows that patients who develop HHV-6 encephalitis have a significantly poor prognosis
International group calls for routine HHV-6 surveillance in all cases of UCBT
New study from Harvard finds heightened risk of HHV-6 PALE for UCBT patients.
A group from the Royal Children’s Hospital in Melbourne, Australia has reported the development of epilepsy after HHV-6 posttransplant limbic encephalitis (PALE) among children receiving stem cell transplantation with cord blood (CBT).
- Page 2 of 2